Global initiative to scale advanced therapeutic treatments to accelerate patient access worldwide. TUCSON, Ariz. and AMSTERDAM, March 26, 2026 /PRNewswire/ -- Critical Path Institute® (C-Path) today ...
The former president of e-mail outsourcer Critical Path Inc. has pleaded guilty to securities fraud, saying he conspired to falsely report the company’s revenue for the third and fourth quarters of ...
TUCSON, Ariz., November 19, 2024 — Critical Path Institute® (C-Path) today announced that its Translational Therapeutics Accelerator (TRxA) program, in partnership with The Leona M. and Harry B.
Critical Path Institute’s Translational Therapeutics Accelerator has invested in the development of QED-203 for advanced and therapy-resistant prostate cancer. Based on research at the University of ...
TUCSON, Ariz., and AMSTERDAM March 26, 2026 — Critical Path Institute® (C-Path) today announced the launch of One to Millions, a global, multi-stakeholder public-private initiative to enable scalable ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results